clinically healthy patient:
Diagnosis of an i n s u l i n o m a in adult patients with confirmed evidence of suspicious symptoms related to hypoglycemia has to be of prime concern in the differential diagnosis of hypoglycemia.H y p e r p l a s i a (e.g.: islet cell or beta-cell-hyperplasia, "nesidioblastosis" in adults, non-insulinoma pancreatogenic hypoglycemia-syndrome / NIPHS, focal hyperplasia) in adults is an extremely rare cause, which may pose diagnostic problems.
Despite significant disabling signs due to adrenergic and / or neuroglycopenic symptoms the patients clinically appear to be healthy and do not present with pathological findings during physical inspection and investigation.
True postpandial hypoglycemia is rare and very often the diagnosis is assumed despite lack of objective data. A different entity is the adrenergic postprandial syndrome (APS), often misclassified as reactive hypoglycemia.
Postprandial hypoglycemia should not be confused with the "early dumping syndrome" presenting with uncomfortable autonomic symptoms, which may occur shortly after intake of rapidly absorbed concentrated sugars and accelerated gastric emptying.
Disease / Cause Remarks Insulinoma
1. mostly benign insulin-secreting tumors of the pancreas
2. malignant insulinoma (10-15%)
3. insulinoma in familial multiple endocrine neoplasia type I (MEN I / menin gene) - pancreatic, parathyroid, and pituitary endocrine tumors
non-insulinoma pancreatogenic hypoglycemia-syndrome
NIPHS
Islet hyperplasia, microadenomatosis
("nesidioblastosis" in adults ?)alimentary postprandial hypoglycemia
"reactive or functional" hypoglycemia
1. prototype: resection of stomach (Billroth) or
2. rapid gastric emptying after carbohydrate-rich nutrients mechanism: GLP-1 (glucagon-like-peptide 1) ?
3. insulin resistance: (i.e.early type-II diabetes with postprandial hyperglycemia, >180 mg/dl) after carbohydrates (30--90 min) and late elevated insulin response / rightward shift of insulin secretion curve
4. increased insulin sensitivity / glucagon ?Alcohol
together with liver disease (cirrhosis) and malnutrition Medical drugs + predisposition
see list (Drugs) factitious hypoglycaemia
Insulin or anti-diabetic drugs (beta-cytotropic agents, i.e. sulfonylureas) extreme physical activity
extreme athletics: marathon, triathlon, ski-longrun mesenchymal non-islet-cell tumors
e.g. fibrosarcoma; elevated "big" IGF II levels (insulin like growth factor II) insulin autoimmune syndrome
AIS / IAISAIS / IAIS : autoimmune insulin syndrome assoc. with autoimmune disease
1. anti-insulin autoantibodies (in Japan / Graves' disease, lupus erythematosus, rheumatoid arthritis, insulin injections)
2.insulin receptor autoantibodies (Lupus erythematosus, scleroderma, primary biliary liver cirrhosis, ITP - purpura, Hashimoto's thyroiditis)PHHI: familial persistent hyperinsulinemic hypoglycemia of "infancy"
diffuse nesidioblastosis / gene mutations (SUR1, Kir6.2 locus)
clinically ill patient
The underlying disease and impaired condition of the patient do not cause problems in the differential diagnosis. Hypoxia and metabolic acidosis (lactic acidosis) lead to inhibition and attenuation of hepatic gluconeogenesis.. Efficient gluconeogenesis is essentially required for a constant blood glucose level (glucose homoeostasis). In addition, gluconeogenesis in normal kidneys contributes to glucose homoeostasis.
Disease / Cause: Internal Medicine Remarks severe liver failure hepatic coma, severe hepatitis: impaired gluconeogenesisrenal insufficiency (uremia) metabolic acidosis, retarded insulin elimination severe cardial insufficiency (cardiomyopathy) hypoxia with alteration of hepatic glucose metabolism , acidosis, liver congestion sepsis acidosis, hypoxia, liver failure, renal failure shock, multiple organ failure acidosis, hypoxia, liver failure, renal failure endocrine crises pituitary insufficiency / adrenal insufficiency / hypothyroidism: lack of ACTH, GH (growth hormone), cortisol, thyroxin medical drugs in diseases of liver / kidneys see list (Drugs) extreme malnutrition anorexia, kachexia; (malignant tumor disease, malnutrition) bone marrow and lymph node diseases leucemia, lymphoma, myeloma (plasmocytoma): antibodies ? inborn errors of metabolism glycogen storage disease, fructose intolerance, galactosemia
Source:
Starke A, Saddig C. Hypoglykämien im Erwachsenenalter. In: Diabetes mellitus. Urban & Fischer, München Jena, 2. Aufl. 2000, S. 775-782
Service FJ. Hypoglycemic disorders. New Engl J Med 332, 1995, 1144-1152